Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TomaGold Borehole EM Survey Confirms Berrigan Deep Zone (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Capricor Therapeutics Inc CAPR

Healthcare Biotechnology
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States. Its lead product candidate is the Deramiocel, an allogeneic cardiosphere-derived cells, which is in phase 3 clinical trial for the... see more

Current News (NDAQ:CAPR)

Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Atkore Inc. (ATKR), Axsome Therapeutics, Inc. (AXSM), Capricor Therapeutics, Inc. (CAPR), and CTO Realty Growth, Inc. (CTO)

GlobeNewswire 1 day ago

Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA Following FDA Review of HOPE-3 Topline Data

GlobeNewswire January 20, 2026

Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar Highlighting Positive Phase 3 HOPE-3 Topline Results in Duchenne Muscular Dystrophy

GlobeNewswire December 16, 2025

Capricor Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock

GlobeNewswire December 5, 2025

Capricor Therapeutics Announces Proposed Public Offering of Common Stock

GlobeNewswire December 4, 2025

Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy

GlobeNewswire December 3, 2025

Capricor Therapeutics Presents New Data Demonstrating a Scalable Framework for Loading Therapeutic Oligonucleotides into Exosomes at AAEV 2025

GlobeNewswire November 24, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Capricor Therapeutics, Inc. (CAPR) Shareholders to Inquire about Securities Investigation

ACCESS Newswire November 20, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Capricor Therapeutics, Inc. (CAPR) And Encourages Shareholders to Connect

ACCESS Newswire November 18, 2025
View More News ››

Opinion & Analysis (NDAQ:CAPR)

Biotech's DMD Therapeutic 'Solidifies the Ground for Potential Pivotal Design'

Streetwise Reports August 14, 2019
View More Opinion ››

Bullboard Posts (NDAQ:CAPR)

Buy buddy buy.

Otherwise FOMO for you fellas out there today anyway so good luck to all of you guys
coolfooldumbguy - July 30, 2025

Sell buddy sell.

Otherwise it is going to be rug pull time for shareholders this morning anyway and so
coolfooldumbguy - July 11, 2025

For next week

<< View Post To Watch Video >>
TheeRook - July 31, 2020

CAPR summary

Not mine   DMD - *There are 20,000 boys with DMD in the USA. 200,000 world-wide. *Around 10,000 USA patients are expected to...
TheeRook - July 28, 2020

RE:Biotechs - Stem Cell Breakthroughs in the Pipeline:

DMD Conference Call   Jul 30
TheeRook - July 27, 2020

RE:RE:RE:RE:RE:15x the float traded already today

Yeah. That’s what I am doing also. It’s nice to get gains in USD..
Oilstockbuyer - May 13, 2020
View more Bullboard ››

Sranan Gold Corp.

Sranan Gold Corp.

Sranan Gold Corp. develops, acquires, and explores mineral properties in Canada. The company primarily explores gold deposits ...
View More »

Podcasts